Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)
- Peiyuan Wang
- Yujie Chen
- Feng Wang
- Mingqiu Chen
- Buhong Zheng
- Derong Zhang
- Qingfeng Zheng
- Jiezhong Wang
- Junqiang Chen
- Huaxin Cai
- Junhua Liu
- Wenshan Zhang
- Changhong Lian
- Juhui Chen
- Yu Lin
- Yuanji Xu
- Rongfang Huang
- Mengxia Lei
- Peng Chen
- Hao He
- Hui Lin
- Xiaofeng Chen
- Hang Zhou
- Weijie Chen
- Wenwei Wei
- Fengnian Zhuang
- Junpeng Lin
- Canhua Huang
- Ni Guan
- Jin Yan
- Shujun Liang
- Shuoyan Liu
- Jiancheng Li
2025-11-03